Cytek grew revenue and losses in the first quarter.
/PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening...
Second quarter revenue grew 32% compared to prior year...
FREMONT, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company...
FREMONT, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will...
/PRNewswire/ -- Recently, Yahui Zhou, the founding partner of Kunlun Capital, won the 36kr 2022 " China 100 Best Investors Voted by Entrepreneurs " award and...
FREMONT, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) announced today that it will...
Company Moves to Make Total Cell Analysis Solutions Available for Clinical Applications in the European Market...
First quarter revenue grew 44% compared to prior year...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...